Prudential Financial’s Intersect ENT, Inc XENT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-12,372
Closed -$464K 2483
2018
Q2
$464K Sell
12,372
-1,389
-10% -$54.5K ﹤0.01% 2069
2018
Q1
$541K Buy
13,761
+2,320
+20% +$84.7K ﹤0.01% 1985
2017
Q4
$370K Buy
+11,441
New +$343K ﹤0.01% 2093
2017
Q3
Sell
-8,200
Closed -$229K 2387
2017
Q2
$229K Buy
+8,200
New +$186K ﹤0.01% 2226
2015
Q3
Sell
-11,600
Closed -$332K 2269
2015
Q2
$332K Buy
+11,600
New +$304K ﹤0.01% 2035

Other funds holding XENT

Prudential Financial's XENT Position: Q3 2018 in Review

Prudential Financial sold out of Intersect ENT, Inc (XENT) in Q3 2018, closing a stake of 12,372 shares — an estimated $464K sold.

Prudential Financial first reported a position in XENT in Q2 2015 and held it in 5 quarters. The position peaked at $541K in Q1 2018. 138 funds tracked by Wall St. Rank hold XENT as of Q3 2018.

  • Prudential Financial reported no remaining Intersect ENT, Inc position as of Q3 2018 after selling out during the quarter.
  • Prudential Financial sold 12,372 Intersect ENT, Inc shares in Q3 2018, an estimated $464K.
  • Prudential Financial first reported a position in Intersect ENT, Inc in Q2 2015 and held it in 5 quarters.
  • Prudential Financial's Intersect ENT, Inc position peaked at $541K in Q1 2018.
  • 138 funds tracked by Wall St. Rank held Intersect ENT, Inc as of Q3 2018.

Based on Prudential Financial's 13F filing for Q3 2018, filed 7 Nov 2018.